On average, stock market experts give TTNP an Buy rating. The average 12-month price forecast for this stock is $0.33, with the high estimate being $1.00, the low estimate being $0.80 and the median estimate amounting to $0.90. This is compared to its latest closing price of $0.33.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Titan Pharmaceuticals Inc. [TTNP] is sitting at 5.00. This is compared to 1 month ago, when its average rating was 5.00.
Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on 08/12/2020.